These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11221470)

  • 1. [Effect of growth hormone and other hormones on trabecular bone structure in acromegaly].
    Zák J; Kapitola J; Povýsil C; Haas T
    Sb Lek; 1999; 100(3):223-33. PubMed ID: 11221470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Duration of the effect of growth hormone on spongious bone].
    Zák J; Kapitola J; Povýsil C; Haas T
    Sb Lek; 1999; 100(3):235-41. PubMed ID: 11221471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interrelation between static parameters of trabecular bones in acromegaly, the STH levels and the duration of the condition. Histomorphometric study].
    Zák J; Povýsil C; Pacovský V; Marek J
    Cas Lek Cesk; 1990 Oct; 129(40):1252-5. PubMed ID: 2257568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative histomorphometric study of acromegalic spongy bone. Formative static parameters].
    Zák J; Povýsil C; Pacovský V; Marek J
    Cas Lek Cesk; 1990 Sep; 129(38):1191-4. PubMed ID: 2224986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender.
    Zgliczynski W; Kochman M; Misiorowski W; Zdunowski P
    Neuro Endocrinol Lett; 2007 Oct; 28(5):621-8. PubMed ID: 17984937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal volumetric trabecular bone mass in acromegalic patients: a longitudinal study.
    Battista C; Chiodini I; Muscarella S; Guglielmi G; Mascia ML; Carnevale V; Scillitani A
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):378-82. PubMed ID: 18616713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of colorectal lesions by using autofluorescence colonoscopy in acromegalics and their relation to serum growth hormone and insulin-like growth factor-1 levels.
    Matyja V; Kos-Kudla B; Foltyn W; Strzelczyk J; Latos W; Marek B; Kajdaniuk D; Karpe J; Ostrowska Z; Sieron-Stoltny K; Sieron A
    Neuro Endocrinol Lett; 2006 Oct; 27(5):639-43. PubMed ID: 17159821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating cytokines in relation to bone mineral density changes in patients with acromegaly.
    Bolanowski M; Daroszewski J; Zatonska K; Arkowska A
    Neuro Endocrinol Lett; 2006; 27(1-2):183-8. PubMed ID: 16648806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is there a relation between weight in rats, bone density, ash weight and histomorphometric indicators of trabecular volume and thickness in the bones of extremities?].
    Zák J; Kapitola J; Povýsil C
    Sb Lek; 2003; 104(3):293-7. PubMed ID: 15224536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacodynamic analysis of octreotide in acromegalic patients.
    Comets E; Mentré F; Grass P; Kawai R; Marbach P; Vonderscher J
    Clin Pharmacol Ther; 2003 Jan; 73(1):95-106. PubMed ID: 12545148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with bone metabolism in acromegalic patients: hypogonadism and female gender.
    Tütüncü NB; Erbaş T
    Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):328-32. PubMed ID: 15216451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of dopaminergic stimulation on growth hormone and prolactin in the treatment of acromegaly].
    Nedvídková J; Felt V
    Vnitr Lek; 1980 Oct; 26(10):988-93. PubMed ID: 7467150
    [No Abstract]   [Full Text] [Related]  

  • 14. Homocysteine levels in acromegaly patients.
    Hekimsoy Z; Ozmen B; Ulusoy S
    Neuro Endocrinol Lett; 2005 Dec; 26(6):811-4. PubMed ID: 16380700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of sexual hormone abnormalities on proximal femur bone mineral density in hemodialysis patients and the possible role of RANKL.
    Doumouchtsis KK; Kostakis AI; Doumouchtsis SK; Grapsa EI; Passalidou IA; Tziamalis MP; Poulakou MV; Vlachos IS; Perrea DN
    Hemodial Int; 2008 Jan; 12(1):100-7. PubMed ID: 18271850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated pulse size, disorderly growth hormone and prolactin secretion with preserved nyctohemeral rhythm distinguish irradiated from surgically treated acromegaly patients.
    van der Klaauw AA; Pereira AM; van Thiel SW; Frolich M; Iranmanesh A; Veldhuis JD; Roelfsema F; Romijn JA
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):489-98. PubMed ID: 17371464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histomorphometry of bone in clinical practice and research].
    Zák J
    Sb Lek; 1995; 96(4):447-9. PubMed ID: 8711400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.
    Carvalho LR; de Faria ME; Osorio MG; Estefan V; Jorge AA; Arnhold IJ; Mendonca BB
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):788-92. PubMed ID: 14974923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotating shift-related changes in hormone levels in intensive care unit nurses.
    Korompeli A; Sourtzi P; Tzavara C; Velonakis E
    J Adv Nurs; 2009 Jun; 65(6):1274-82. PubMed ID: 19374673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue?
    Jallad RS; Musolino NR; Kodaira S; Cescato VA; Bronstein MD
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):310-5. PubMed ID: 17555503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.